A Phase III, Randomised, Double-Blind, Dose-Response, Stratified, Placebo-Controlled Study Evaluating the Safety and Efficacy of SPD476 Versus Placebo Over 104 Weeks in the Prevention of Recurrence of Diverticulitis.
A Phase III, Randomised, Double-Blind, Dose-Response, Stratified, Placebo-Controlled Study Evaluating the Safety and Efficacy of SPD476 Versus Placebo Over 104 Weeks in the Prevention of Recurrence of Diverticulitis.
The purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.
Inclusion Criteria:
Exclusion Criteria:
Milwaukee, Wisconsin 53209, United States
Nantes, Brittany Region 44033, France